Securities fraud litigation history and active cases
In Litigation
1
Settlement
0
Closed
1
Total Settlement
$8.5M
23-1122 • May 14, 2021
Class Period Start
October 14, 2020
Class Period End
May 11, 2021
PSLRA Deadline
July 13, 2021
Case Allegations
10b5 + Sec11
10b-5 Statutes of Repose
Oct 14, 2023
Sec11 Statutes of Repose
Oct 14, 2023
Country
United States
Court
Federal Court
Aug 7, 2023
May 19, 2023
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Oct 17, 2022
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Dec 7, 2021
A new complaint has been filed on behalf of certain investors in Array Technologies, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Dec 3, 2021
A new complaint has been filed on behalf of certain investors in Array Technologies, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
1:17cv2789 • November 20, 2017
Class Period Start
June 29, 2016
Class Period End
March 21, 2017
PSLRA Deadline
January 22, 2018
Case Allegations
10b5
Statutes of Repose
Jun 29, 2019
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
August 17, 2021
Settlement Fund
$8,500,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or acquired between June 30, 2016 and March 17, 2017, inclusive.
Claim Administrator
JND Legal Administration
Array Biopharma Securities Litigation Claims Administrator
JND Legal Administrator
P.O. Box 91406 Seattle, WA 98111
+1 000-000-0000
Settlement Website
-Hearing Date
October 29, 2021
Opt-out Deadline
October 4, 2021
Settlement Note
Download hereProof Of Claim
Download here
Apr 17, 2023
Disbursement Approved
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Dec 3, 2021
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
May 19, 2021
Class Certification Denied
The court has denied the request to proceed as a class action. This means the case cannot move forward on behalf of the proposed group of investors unless that decision changes or the court later approves a revised request.
May 4, 2021
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
May 4, 2021
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
TOP
